Atea Pharmaceuticals, Inc.
NASDAQ:AVIR
3.99 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 143.823 | 646.709 | 764.375 | 850.117 | 21.661 | 34.492 |
| Short Term Investments
| 434.283 | 458.249 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 578.106 | 646.709 | 764.375 | 850.117 | 21.661 | 34.492 |
| Net Receivables
| 0 | 0 | 0 | 5.815 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 12.349 | 14.213 | 8.028 | 7.545 | 0.249 | 0.206 |
| Total Current Assets
| 590.455 | 660.922 | 772.403 | 863.477 | 21.91 | 34.698 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 3.117 | 4.094 | 0.023 | 0.048 | 0.041 | 0.056 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0.198 | 0.305 | 0.107 | 0.107 | 0.107 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 1.396 | 1.494 | 0.161 | 0 | 0.015 | 0 |
| Total Non-Current Assets
| 4.513 | 5.786 | 0.489 | 0.155 | 0.163 | 0.163 |
| Total Assets
| 594.968 | 666.708 | 772.892 | 863.632 | 22.073 | 34.861 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 4.252 | 2.551 | 4.534 | 0.06 | 0.548 | 0.391 |
| Short Term Debt
| 0.76 | 0.721 | 0.197 | 0 | -0.2 | -0.2 |
| Tax Payables
| 0 | 0.099 | 2.572 | 0 | 0 | 0 |
| Deferred Revenue
| -0 | 0 | -0.197 | 301.367 | 0.2 | 0.2 |
| Other Current Liabilities
| 27.364 | 15.206 | 52.349 | 14.368 | 1.887 | 1.369 |
| Total Current Liabilities
| 32.376 | 18.478 | 56.883 | 315.795 | 2.435 | 1.76 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 1.642 | 2.403 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 5.758 | 5.255 | 5.932 | 0.036 | 69.209 | 69.262 |
| Total Non-Current Liabilities
| 7.4 | 7.658 | 5.932 | 0.036 | 69.209 | 69.262 |
| Total Liabilities
| 39.776 | 26.136 | 62.815 | 315.831 | 71.644 | 71.022 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 0 | 863.632 | 69.114 | 69.114 |
| Common Stock
| 0.083 | 0.083 | 0.083 | 0.082 | 0.01 | 0.01 |
| Retained Earnings
| -195.835 | -59.879 | 56.03 | -65.16 | -54.213 | -40.179 |
| Accumulated Other Comprehensive Income/Loss
| 0.207 | -0.684 | -0 | -863.632 | -69.114 | -69.114 |
| Other Total Stockholders Equity
| 750.737 | 701.052 | 653.964 | 612.879 | 4.632 | 4.008 |
| Total Shareholders Equity
| 555.192 | 640.572 | 710.077 | 547.801 | -49.571 | -36.161 |
| Total Equity
| 555.192 | 640.572 | 710.077 | 547.801 | -49.571 | -36.161 |
| Total Liabilities & Shareholders Equity
| 594.968 | 666.708 | 772.892 | 863.632 | 22.073 | 34.861 |